Iowa Healthcare Partners,

On Nov 30th's COVID-19 Therapeutics Brief (11.30.22) includes detailed information on the following highlights.

• Allocations for Monoclonal Antibodies, Pre-Exposure Prophylaxis Treatment and Oral Antivirals
• Expiration Dating Extension Reminder
• Bebtelovimab News
• Evusheld Update
• Information for Iowa-Licensed Pharmacists on Revised EUA for Paxlovid

Healthcare provider questions regarding COVID-19 therapeutics can be directed to the C19 Therapeutics Call Center at (515) 281-7317 or emailed to  C19Therapeutics@idph.iowa.gov.